Medication Shortage Affects Cancer Patients

Pharmacists have warned that one of the worst examples of medical bottlenecks affects cancer patients. Creon, a pancreas enzyme replacement therapy (PERT), helps with digestion and is required by patients with pancreatic cancer, cystic fibrosis, and chronic pancreatitis. It is believed that more than 61,000 patients in Great Britain need this medication.

The Impact of the Shortage

According to the National Pharmacy Association, some patients have to "skip meals" to ration their medication due to the shortage. Without the drug, patients lose weight and strength, which means their ability to undergo treatment such as chemotherapy is reduced. Some experts have continued the defect until next year.

Cause of the Shortage

The Department of Health and Social Care has expanded a serious shortage protocol for Kreon, which has been in existence for a year. This shows concern about the lack of medication and enables pharmacists to give patients an alternative – although they argue that other medications are also poor. A spokesman for the department said that the "European supply problems" were caused by restrictions on the production of offer offers.

Additional Layer of Stress

The National Pharmacy Association said that more than three quarters of members who were treated in a recently carried out survey are of the view that the current agreements for managing the bottlenecks are insufficient. Some reported that patients skipped meals and moved long distances to maintain the medication. One said it was the "worst lack of stocks" with which they ever had to deal with.

Patients’ Struggles

A 64-year-old patient, who was diagnosed with pancreatic cancer in 2023, initially received 15 boxes of Creon every month to tolerate their chemotherapy. She can now only get six or seven and has to skip snacks. The defect has deeply influenced her mental health. She said that the defect had created an "additional layer of stress and worries" while trying to put her life back together after the diagnosis.

Desperate Measures

Thousands of people who are affected by pancreatic cancer have to take desperate measures just to digest their food and absorb nutrients – something that most of us take for granted. It is completely unacceptable that patients have to take desperate measures that result in their health, well-being, and justification for the risk of treatment.

Response from Authorities

A spokesman for the Ministry of Health and Social Affairs said that they knew how frustrating and disturbing "medical care problems can be for patients and clinicians who take care of them. The European supply problems with Kreon are caused by limited availability of raw materials and restrictions on production capacity. We work closely with the industry and the NHS to alleviate the effects on the patients and to solve the problems as soon as possible."